Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts

Generated: March 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018279

« Back to Dashboard

NDA 018279 describes K-TAB, which is a drug marketed by Abbvie and is included in one NDA. It is available from nineteen suppliers. Additional details are available on the K-TAB profile page.

The generic ingredient in K-TAB is potassium chloride. There are two hundred and thirty-four drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
Summary for 018279
Ingredient:potassium chloride
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 018279
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
K-TAB potassium chloride TABLET, EXTENDED RELEASE;ORAL 018279 NDA AbbVie Inc. 0074-3023 N 0074-3023-13
K-TAB potassium chloride TABLET, EXTENDED RELEASE;ORAL 018279 NDA AbbVie Inc. 0074-3023 N 0074-3023-53

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength10MEQ
Approval Date:Approved Prior to Jan 1, 1982TE:AB3RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength8MEQ
Approval Date:Aug 1, 1988TE:BCRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength20MEQ
Approval Date:Nov 25, 2013TE:AB2RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
Harvard Business School
Cantor Fitzgerald
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.